Circulating activated immune cells as a potential blood biomarkers of non-small cell lung cancer occurrence and progression

Treatment for non-small cell lung cancer (NSCLC) has greatly improved in recent years. However, noninvasive early screening for carcinogenesis and progression unclear. The aim of this study was to explore the ...

Source: BMC Pulmonary Medicine - September 6, 2021 Category: Respiratory Medicine Authors: Yingyi Wang, Na Zhou, Rui Zhu, Xiaoyuan Li, Zhao Sun, Yang Gao, Wei Liu, Changting Meng, Yuping Ge, Chunmei Bai, Taisheng Li and Hongsheng Liu Tags: Research Source Type: research